Summary
Clostridium botulinum type toxin A (BoTx) blocks stimulus-induced acetylcholine (ACh) release from presynaptic nerve terminals at peripheral neuromuscular junctions. However, the detailed mechanism of this effect remains elusive. One obstacle in solving this problem is the lack of a suitable in vitro homogenous cholinergic neuronal model system. We studied the clonal pheochromocytoma PC12 cell line to establish such a model. PC12 cells were differentiated in culture by treatment with 50 ng/ml nerve growth factor (NGF) for 4 days to enhance cellular ACh synthesis and release properties. Stimulation of these cells with high K+ (80 mM) in the perfusion medium markedly increased calcium-dependent [3H]ACh release compared to undifferentiated cells. Stimulated [3H]ACh release was totally inhibited by pretreatment of cells with 2 nM BoTx for 2 h. BoTx inhibition of [3H]ACh release was time- and concentration-dependent. A 50% inhibition was obtained after 2 h incubation with a low (0.02 nM) toxin concentration. The time required for 2 nM BoTx to cause a measurable inhibition (18%) of stimulated [3H]ACh release was 30 min. Botulinum toxin inhibition of stimulated ACh release was prevented by toxin antiserum and heat treatment, suggesting the specificity of the toxin effect. Our results show that by differentiation with NGF, PC12 cells can be shifted from an insensitive to a sensitive state with respect to BoTx inhibition of stimulated ACh release. This cell line, therefore, may serve as a valuable in vitro cholinergic model system to study the mechanism of action of BoTx.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ashton, A. C.; Dolly, J. O. Characterization of the inhibitory action of botulinum neurotoxin type A on the release of several transmitters from rat cerebrocortical synaptosomes. J. Neurochem. 50:1808–1816; 1988.
Bittner, M. A.; DasGupta, B. R.; Holz, R. W. Isolated light chains of botulinum neurotoxin inhibit exocytosis: studies in digitonin-permeabilized cells. J. Biol. Chem. 264:10354–10360; 1989.
Black, J. D.; Dolly, J. O. Interaction of125I-labelled botulinum neurotoxins with nerve terminals. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves. J. Cell Biol. 103:521–534; 1986.
Dolly, J. O.; Ashton, A. C.; Evans, D. M., et al. Molecular action of botulinum neurotoxins role: role of acceptors in targeting to cholinergic nerves and in the inhibition of the release of several transmitters. In: Dowdall, M. J.; Hawthorne, J. A., eds. Cellular and molecular basis of cholinergic function. Chichester, UK: Ellis Horwood; 1987:517–533.
Dudant, Y.; Esquerda, J. E.; Loctin, F., et al. Botulinum toxin inhibits quantal acetylcholine release and energy metabolism in the torpedo electric organ. J. Physiol. 385:677–692; 1987.
Fink, D. W.; Guroff, G. Nerve growth factor stimulation of arachidonic acid release from PC12 cells: independence from phosphoinositide turnover. J. Neurochem. 55:1716–1726; 1990.
Gansel, M.; Penner, R.; Dreyer, F. Distinct sites of action of clostridial neurotoxins revealed by double-poisoning of mouse motor terminals. Pfluegers Arch. Eur. J. Physiol. 409:404–416; 1987.
Green, L. A.; Tischler, A. PC12 pheochromocytoma cultures in neurobiological research. Adv. Cell. Neurobiol. 3:373–414; 1987.
Hambleton, P. Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use. J. Neurol. 239:16–20; 1992.
Lomneth, R.; Martin, T. F. J.; DasGupta, B. R. Botulinum neurotoxin light chain inhibits norepinephrine secretion in PC12 cells at an intracellular membranous or cytoskeletal site. J. Neurochem. 57:1413–1421; 1991.
Maisey, E. A.; Wadsworth, J. D. F.; Poulain, B., et al. Involvement of the constituent chains of botulinum neurotoxins A and B in the blockade of neurotransmitter release. Eur. J. Biochem. 177:683–691; 1988.
McGee, R.; Simpson, P.; Christian, C., et al. Regulation of acetylcholine release from neuroblastoma x glioma hybrid cells. Proc. Natl. Acad. Sci. USA 75:1314–1318; 1978.
McInnes, C.; Dolly, J. O. Ca2+-dependent noradrenaline release from permeabilized PC12 cells is blocked by botulinum neurotoxin A or its light chain. FEBS Lett. 261:323–326; 1990.
Ray, P.; Middleton, W. The role of arachidonic acid in stimulated acetylcholine release from PC12 cells. Pharmacologist 34:187; 1992.
Ray, P.; Berman, J. D.; Schuster, B. G., et al. A novel insight into the mechanism of action of botulinum toxin in a cholinergic neuronal cell culture model. Soc. Neurosci. 18:790; 1992.
Richter-Landsberg, C.; Jastorff, B. The role of cAMP in nerve growth factor-promoted neurite outgrowth in PC12 cells. J. Cell Biol. 102:821–829; 1986.
Sandberg, K.; Berry, C. J.; Rogers, T. B. Studies on the intoxication pathway of tetanus toxin in the rat pheochromocytoma (PC12) cell line. J. Biol. Chem. 264:5679–5686; 1989.
Schantz, E. J.; Johnson, E. A. Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol. Rev. 56:80–99; 1992.
Schiavo, G.; Ferrari, G.; Rossetto, O., et al. Specific cross-linking of tetanus toxin to a protein of NGF-differentiated PC12 cells. FEBS Lett. 290:227–230; 1991.
Scott, A. B.; Rosenbaum, A. L.; Collins, C. C. Pharmacological weakening of extraocular muscles. Invest. Ophthalmol. 12:924–927; 1973.
Shone, C. C.; Melling, J. Inhibition of calcium-dependent release of noradrenaline from PC12 cells by botulinum type-A neurotoxin—long-term effects of the neurotoxin on intact cells. Eur. J. Biochem. 207:1009–1016; 1992.
Simpson, L. L. Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. J. Pharmacol. Exp. Ther. 212:16–21; 1980.
Simpson, L. L. The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol. Rev. 33:155–188; 1981.
Simpson, L. L. In botulinum neurotoxin and tetanus toxin. In: Simpson, L. L., ed. San Diego, CA: Academic Press; 1989:153–178.
Wellhoner, H. H.; Neville, D. M., Jr. Tetanus toxin binds with high affinity to neuroblastoma x glioma hybrid cells NG108-15 and impairs their stimulated acetylcholine release. J. Biol. Chem. 262:17374–17378; 1987.
Author information
Authors and Affiliations
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/BF02634558.
Rights and permissions
About this article
Cite this article
Ray, P. Botulinum toxin a inhibits acetylcholine release from cultured neurons in vitro. In Vitro Cell Dev Biol - Animal 29, 456–460 (1993). https://doi.org/10.1007/BF02639379
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02639379